Sponsor or institution

Clinical trials and research at Medicines Development for Global Health

• 2Clinical trials
• 7Countries

All recruiting trials (2)

• Dovramilast in Leprosy Type 2 Reaction (ENL)

  A study tests whether dovramilast, at 100 mg or 150 mg, works as well as standard treatments for leprosy type 2 reaction in adults.

  Recruiting at 4 sites Phase 2 Medicines Development for Global Health · Seattle, Washington and 5 other locations · NCT07172659

• Better options for treating lymphatic filariasis and other infections in communities

  This trial tests whether a three-drug regimen (moxidectin, diethylcarbamazine, and albendazole) can clear lymphatic filariasis, scabies, and strongyloidiasis in people in affected communities, compared with the standard regimen (ivermectin, DEC, and albendazole).

  Recruiting Phase 3 Medicines Development for Global Health · Suva · NCT07159373

Quick answers

How many clinical trials run by Medicines Development for Global Health are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in Benin (1 trial), Côte d’Ivoire (1 trial), Indonesia (1 trial), Madagascar (1 trial), Philippines (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →